Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 1, 2001, Pages 183-193

  Busheé, Gerald R ^a   Sunshine, Jonathan H ^b   Simon, Carol ^c   Schepps, Barbara ^b,d,e  

^a GEORGE MASON UNIVERSITY   (United States)

^b AMERICAN COLLEGE OF RADIOLOGY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d BROWN UNIVERSITY   (United States)

^e RHODE ISLAND HOSPITAL   (United States)

Author keywords

Apoptosis; I B; NF B; Proteasome inhibitor PS 341; Radiation

Indexed keywords

CHEMOTHERAPY; ENZYME INHIBITION; IONIZING RADIATION; TUMORS;

RADIOSENSITIVITY;

PROTEINS;

BORTEZOMIB; COBALT 60; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; PROTEASOME INHIBITOR; RADIOSENSITIZING AGENT; TUMOR NECROSIS FACTOR; UBIQUITIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GRAFT; CELL GROWTH; CELL SURVIVAL; CLONOGENIC ASSAY; COBALT THERAPY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; ELECTROPHORETIC MOBILITY; FEMALE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NICK END LABELING; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION; REGULATORY MECHANISM; TUMOR VOLUME; XENOGRAFT;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BORONIC ACIDS; COLORECTAL NEOPLASMS; CYSTEINE ENDOPEPTIDASES; DNA-BINDING PROTEINS; FEMALE; HUMANS; I-KAPPA B PROTEINS; MICE; MICE, NUDE; MULTIENZYME COMPLEXES; NF-KAPPA B; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; REPRESSOR PROTEINS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035341494     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01446-8     Document Type: Article

References (30)

1. The NF-κB and IκB proteins; New discoveries and insights
2. The transcription factor NF-kappaB; Control of oncogenesis and cancer therapy resistance
3. NF-κB anti-apoptosis; Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
4. Induction of transcription of 'immediate early genes' by low dose ionizing radiation
5. Radiation induction of immediate early genes; Effectors of the radiation-stress response
6. Suppression of TNFα-induced apoptosis by NF-κB
7. An essential role for NF-κB in preventing TNFα-induced cell death
8. Control of inducible chemoresistance; Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
9. NF-κB; Ten years after
10. TNF- and cancer therapy-induced apoptosis; Potentiation by inhibitors of NF-κB
11. Proteasome inhibitors; A novel class of potent and effective antitumor agents
12. Proteasome inhibitors as new anti-cancer agents; Biological activity and in vivo detection assay
13. The proteasome inhibitor PS-341 in cancer therapy
14. Inhibition of pro-inflammatory molecule production by adenovirus-mediated expression of NF-κB super-repressor in human intestinal epithelial cells
15. Proteasome inhibitors activate stress kinases and induce HSP-72. Diverse effects on apoptosis
16. Mean inactivation dose; A useful concept for the inter-comparison of human cell survival curves
17. Inhibition of NF-κB, clonogenicity, and radiosensitivity of human cancer cells
18. Radiosensitivity and transcription factor NF-κB; Progress and pitfalls
19. Effect of anti-sense c-raf-1 on tumorigenicity and radiation-sensitivity of human squamous carcinoma
20. The DNA-dependent protein kinase in the activation of NF-κB following DNA damage
21. Basal phosphorylation of the PEST domain in the IκBβ regulates its functional interaction with the c-rel oncogene product
22. Post-induction transcriptional repressor of E-selectin and vascular cell adhesion molecule